ASSESSING FRAILTY-ASSOCIATED CHARACTERISTICS AND OUTCOMES IN THE DUAL ANTIPLATELET THERAPY (DAPT) STUDY USING MEDICARE CLAIMS: INSIGHTS FROM THE EXTEND-DAPT STUDY

Frailty is not routinely assessed in clinical studies. The impact of frailty on outcomes following percutaneous coronary intervention (PCI) with dual antiplatelet therapy (DAPT) is therefore uncertain. We evaluated 1326 patients age ≥65 years in the DAPT Study, a randomized trial comparing 30...